C
Carlos Perez-Vega
Researcher at Monterrey Institute of Technology and Higher Education, Guadalajara
Publications - 17
Citations - 48
Carlos Perez-Vega is an academic researcher from Monterrey Institute of Technology and Higher Education, Guadalajara. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 4 citations.
Papers
More filters
Journal ArticleDOI
Spontaneous intracranial hypotension: key features for a frequently misdiagnosed disorder.
TL;DR: The wide variety of neurological manifestations and complications seen in patients with SIH as well as the most common features described on imaging studies are described, including both subjective and objective measurements, in order to lead the clinician to a correct diagnosis.
Journal ArticleDOI
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study
Andres Ramos-Fresnedo,Michael W. Pullen,Carlos Perez-Vega,Ricardo A. Domingo,Oluwaseun O. Akinduro,Joao Paulo Almeida,Paola Suarez-Meade,Lina Marenco-Hillembrand,Mark E. Jentoft,Bernard R. Bendok,Daniel M. Trifiletti,Kaisorn L. Chaichana,Alyx B. Porter,Alfredo Quiñones-Hinojosa,Terence C. Burns,Sani H. Kizilbash,Erik H. Middlebrooks,Wendy Sherman +17 more
TL;DR: The presence of contrast enhancement and MGMT methylation seem to affect the clinical behavior of this subset of tumors and molGBM has a similar OS but significantly longer PFS when compared to histGBM.
Journal ArticleDOI
Cerebral venous thrombosis during the COVID-19 Pandemic: A multi-center experience
Ricardo A. Domingo,Andres Ramos-Fresnedo,Carlos Perez-Vega,Shashwat Tripathi,Michael W. Pullen,Jaime Martinez,Young Erben,James F. Meschia,Rabih G. Tawk +8 more
TL;DR: In this paper , the authors reviewed demographic, clinical, and radiographic characteristics of non-pyrogenic, non-traumatic CVT cases at a multi-center institution between March 2020 and December 2021.
Journal ArticleDOI
Mesenchymal stem cell therapy for focal epilepsy: A systematic review of preclinical models and clinical studies
Andres Ramos-Fresnedo,Carlos Perez-Vega,Ricardo A. Domingo,S. J. Lee,Ralph B. Perkerson,Abba C. Zubair,Takahisa Kanekiyo,William O. Tatum,Alfredo Quiñones-Hinojosa,Erik H. Middlebrooks,Sanjeet S. Grewal +10 more
TL;DR: Both preclinical and clinical studies have shown MSC therapy to be safe and preliminary effective, thus warranting further studies to investigate its therapeutic potential.
Journal ArticleDOI
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis
Carlos Perez-Vega,Andres Ramos-Fresnedo,Shashwat Tripathi,Ricardo A. Domingo,Krishnan Ravindran,Joao Paulo Almeida,Jennifer L. Peterson,Daniel M. Trifiletti,Kaisorn L. Chaichana,Alfredo Quiñones-Hinojosa,Susan L. Samson +10 more
TL;DR: The data show that either TSS or SRS represent viable treatment options to achieve remission for this subset of patients and both TSS and SRS are possible approaches for the treatment of recurrent or persistent CD after a first TSS.